Micro guide catheters are medical devices used in minimally invasive surgeries and procedures to accurately guide and deliver stents, balloons and other medical devices to treat vascular diseases. Their small diameter and precise control allow physicians to reach tight anatomical spaces with ease. The global micro guide catheters market is driven by the aging population which is more susceptible to developing cardiovascular and neurological disorders. Additionally, the rising prevalence of lifestyle diseases such as diabetes which increases the risk of vascular problems also contributes to market growth.

The global micro guide catheters market is estimated to be valued at US$ 227.91 Mn in 2023 and is expected to exhibit a CAGR of 5.7% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.

Market Opportunity:

Increased adoption of minimally invasive surgeries presents a lucrative opportunity for the micro guide catheters market. Minimally invasive procedures are preferred over traditional open surgeries since they are less painful, have shorter recovery times and results in fewer complications. Use of micro guide catheters allows physicians to perform complex interventions through small entry points resulting in lesser incisions. Their precise maneuvering capabilities aid in safely reaching targeted locations inside the body. As patient awareness regarding benefits of minimally invasive options increases, the demand for technologically advanced micro guide catheters enabling such surgeries is expected to experience significant growth over the forecast period. This will, in turn, propel the overall expansion of the micro guide catheters market.

Porter’s Analysis

Threat of new entrants: The global micro guide catheters market has moderate threat of new entrants due to requirement of high R&D investment and presence of stringent regulations imposed by regulatory bodies.

Bargaining power of buyers: Buyers have moderate bargaining power due to presence of substantial number of players offering micro guide catheters.

Bargaining power of suppliers: Suppliers have low-moderate bargaining power due to availability of substitute raw materials.

Threat of new substitutes: Threat of new substitutes is low as micro guide catheters have proven benefits and current substitutes are not able to fulfill all clinical needs.

Competitive rivalry: The global market witnesses high competitive rivalry due to presence of key players focusing on new product launches and geographic expansion.

SWOT Analysis

Strengths: Increasing incidence of cardiovascular, neurovascular and peripheral vascular diseases. Advanced features of micro guide catheters such as flexibility, hydrophilic coatings for torque and lateral movement.

Weaknesses: High cost associated with micro guide catheters procedures. Risk of radiation exposure to patients and physicians during imaging-guided procedures.

Opportunity: Growth opportunities in emerging markets. Increasing demand for minimally invasive procedures.

Threats: Stringent regulatory requirements for new product approvals. Reimbursement issues in developing countries.

Key Takeaways

The global micro guide catheters market is expected to witness high growth during the forecast period due to rising prevalence of cardiovascular diseases, neurovascular diseases and peripheral vascular diseases. Global Micro Guide Catheters Market Size is estimated to be valued at US$ 227.91 Mn in 2023 and is expected to exhibit a CAGR of 5.7% over the forecast period 2024 to 2031.

Regional analysis indicates that North America dominates the global market and is expected to grow at a steady pace during the forecast period mainly due to development of advanced healthcare facilities and increasing geriatric population suffering from cardiovascular diseases. Europe holds the second largest market share owing to increasing healthcare expenditure.

Key players operating in the micro guide catheters market are Zealand Pharma A/S, Eli Lilly and Company, Xeris Pharmaceuticals, Inc., Rezolute, Inc., Hanmi Pharm.Co., Ltd., Fresenius Kabi AG, Eiger BioPharmaceuticals.,Crinetics Pharmaceuticals, Inc., AmideBio,LLC, Jolly Healthcare, e5 Pharma,LLC, Merck & Co.,Inc., Novo Nordisk A/S, Amphaster Pharmaceuticals,Inc., USV Private Limited, Teva Pharmaceutical Industries Ltd. These players are focusing on product launches and approvals to strengthen their presence across the globe.

Get More Insights on this Topic- https://www.marketwebjournal.com/micro-guide-catheters-market-growth-value-and-insights/